{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:58:38Z","timestamp":1754110718414},"reference-count":24,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T00:00:00Z","timestamp":1342656000000},"content-version":"vor","delay-in-days":11432,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[1981,4]]},"abstract":"<jats:p><jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>At 37\u00b0C in 0.1 <jats:sc>m<\/jats:sc> NaCl the pK<jats:sub>a<\/jats:sub> of hyoscine (10 m<jats:sc>m<\/jats:sc>) is 7.53; the non\u2010protonated form has about one\u2010tenth of the affinity (log <jats:italic>K<\/jats:italic> = 8.58) of the protonated form (log <jats:italic>K<\/jats:italic> = 9.58) for muscarine\u2010sensitive receptors of the guinea\u2010pig ileum at 37\u00b0C.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>In the same conditions the pK<jats:sub>a<\/jats:sub> of hyoscine <jats:italic>N<\/jats:italic>\u2010oxide is 5.78 and the non\u2010protonated form is inactive on the ileum whereas the protonated form is highly active with log <jats:italic>K<\/jats:italic> estimated to be 9.9, at least as active as hyoscine methobromide (log <jats:italic>K<\/jats:italic> = 9.85).<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Hyoscine methobromide appears to occupy less space in water than atropine methobromide; hyoscine hydrochloride occupies less space than hyoscyamine hydrochloride: the non\u2010protonated forms are slightly bigger. Hyoscine <jats:italic>N<\/jats:italic>\u2010oxide hydrobromide is slightly smaller than hyoscine methobromide but the removal of the proton is accompanied by a reduction in volume, such as is seen with other zwitterions.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>These differences in volume indicate a reduction in entropy on solution which may allow a greater increase in entropy on binding to receptors and hence greater affinity. The higher activity of hyoscine itself could also be due to the presence of the <jats:italic>N<\/jats:italic>\u2010methyl group in the axial position, rather than equatorial as in hyoscyamine or atropine.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The different position of the <jats:italic>N<\/jats:italic>\u2010methyl group may partly explain why the pK<jats:sub>a<\/jats:sub> of hyoscine is 2 units lower than that of hyoscyamine or atropine. It is also probable that the unionized form of hyoscine is stabilized by hydration.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Although hyoscine <jats:italic>N<\/jats:italic>\u2010oxide is only weakly active at pH 7.6, it is present in a highly active form in the acid environment of the stomach and so might be expected to act selectively at this site.<\/jats:p><\/jats:list-item>\n<\/jats:list><\/jats:p>","DOI":"10.1111\/j.1476-5381.1981.tb09146.x","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T15:44:00Z","timestamp":1342712640000},"page":"657-664","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["AFFINITIES OF THE PROTONATED AND NON\u2010PROTONATED FORMS OF HYOSCINE AND HYOSCINE <i>N<\/i>\u2010OXIDE FOR MUSCARINIC RECEPTORS OF THE GUINEA\u2010PIG ILEUM AND A COMPARISON OF THEIR SIZE IN SOLUTION WITH THAT OF ATROPINE"],"prefix":"10.1111","volume":"72","author":[{"given":"R.B.","family":"BARLOW","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ELIZABETH A.","family":"WINTER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,19]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1976.tb10377.x"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1980.tb10904.x"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1979.tb13697.x"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1980.tb07908.x"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1980.tb07909.x"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1973.tb17258.x"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00263a003"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00263a037"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1980.tb10905.x"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1974.tb09636.x"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1965.tb01752.x"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00283a021"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00330a024"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1021\/j100892a515"},{"key":"e_1_2_1_16_1","first-page":"2","volume-title":"Pharmacological Experiments on Isolated Preparations","author":"EDINBURGH STAFF","year":"1974"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1039\/p29770002016"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/j100887a046"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1139\/v71-544"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/je60057a016"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1021\/cr60270a001"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1039\/c29690001001"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/228673a0"},{"key":"e_1_2_1_24_1","first-page":"351","volume-title":"Dissociation Constants of Organic Bases in Aqueous Solution","author":"Perrin D.D.","year":"1965"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/bbpc.19310370860"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.1981.tb09146.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.1981.tb09146.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T12:53:56Z","timestamp":1699102436000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.1981.tb09146.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1981,4]]}},"alternative-id":["10.1111\/j.1476-5381.1981.tb09146.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.1981.tb09146.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,4]]},"assertion":[{"value":"2012-07-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}